MLKL and colonic neoplasm: In order to do this, we used immunohistochemistry to determine the levels of phosphorylated MLKL (pMLKL) in pre-treatment biopsy samples from a cohort of human esophagus cancer patients and a cohort of human colon cancer patients (Figure 5, Supplementary Table S2).